Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0111 | 0.1104 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.0435 | 0.0435 |
Echinococcus multilocularis | jun protein | 0.0267 | 0.3301 | 0.478 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.0435 | 0.063 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0199 | 0.0199 |
Brugia malayi | bZIP transcription factor family protein | 0.0267 | 0.3301 | 0.3301 |
Entamoeba histolytica | hypothetical protein | 0.0111 | 0.1104 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0199 | 0.0288 |
Loa Loa (eye worm) | hypothetical protein | 0.026 | 0.3198 | 0.3198 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0102 | 0.0979 | 0.0979 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0032 | 0.0046 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.0435 | 0.063 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.0435 | 0.063 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.1327 | 0.1327 |
Schistosoma mansoni | hypothetical protein | 0.0523 | 0.6905 | 1 |
Echinococcus granulosus | jun protein | 0.0267 | 0.3301 | 0.478 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0199 | 0.0288 |
Leishmania major | hypothetical protein, conserved | 0.0078 | 0.0636 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0199 | 0.0288 |
Entamoeba histolytica | hypothetical protein | 0.0111 | 0.1104 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0078 | 0.0636 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0199 | 0.0288 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0102 | 0.0979 | 0.1418 |
Schistosoma mansoni | hypothetical protein | 0.0217 | 0.2596 | 0.376 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.0435 | 0.063 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0267 | 0.3301 | 0.478 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0078 | 0.0636 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.0435 | 0.0435 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0199 | 0.0288 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.0435 | 0.063 |
Schistosoma mansoni | hypothetical protein | 0.0523 | 0.6905 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0111 | 0.1104 | 0.1599 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0199 | 0.0288 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0267 | 0.3301 | 0.478 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0743 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.1327 | 0.1327 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.1327 | 0.1327 |
Echinococcus multilocularis | geminin | 0.0523 | 0.6905 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0199 | 0.0288 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.0435 | 0.0435 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0035 | 0.0032 | 0.0046 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.0636 | 0.0636 |
Loa Loa (eye worm) | nuclear hormone receptor | 0.0097 | 0.0902 | 0.0902 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.0435 | 0.0435 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0035 | 0.0032 | 0.0046 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.0435 | 0.063 |
Schistosoma mansoni | jun-related protein | 0.0217 | 0.2596 | 0.376 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0102 | 0.0979 | 0.1418 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.0435 | 0.0435 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0078 | 0.0636 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0033 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.0435 | 0.063 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.091 | 0.091 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0078 | 0.0636 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0078 | 0.0636 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0078 | 0.0636 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0111 | 0.1104 | 0.1599 |
Schistosoma mansoni | hypothetical protein | 0.0111 | 0.1104 | 0.1599 |
Brugia malayi | hypothetical protein | 0.005 | 0.0248 | 0.0248 |
Entamoeba histolytica | hypothetical protein | 0.0111 | 0.1104 | 0.5 |
Brugia malayi | hypothetical protein | 0.021 | 0.2493 | 0.2493 |
Echinococcus granulosus | geminin | 0.0523 | 0.6905 | 1 |
Brugia malayi | RNA binding protein | 0.0064 | 0.0435 | 0.0435 |
Brugia malayi | hypothetical protein | 0.0078 | 0.0636 | 0.0636 |
Brugia malayi | hypothetical protein | 0.0111 | 0.1104 | 0.1104 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.0199 | 0.0199 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0078 | 0.0636 | 1 |
Onchocerca volvulus | 0.0743 | 1 | 1 | |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0111 | 0.1104 | 0.1599 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.